PHARMACEUTICAL INDUSTRY TO BENEFIT FROM EU-SOUTH KOREA TRADE DEAL
October 1st, 2009
BY KEITH NUTHALL
THE EUROPEAN Commission has unveiled details of how the new South Korean-European Union (EU) trade agreement will benefit pharmaceutical manufacturers.
The deal will essentially make pharmaceutical trades between the two parties duty free - as many medicines are already traded between the EU-South Korea without tariffs. As regards EU tariffs on South Korean exports, the agreement will see 6.5% duties on gel preparations used as lubricants for medicines and also sterile surgical or dental adhesion barriers removed. Regarding South Korean imports ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.